Peptide therapeutic conjugates and uses thereof

Details for Australian Patent Application No. 2009322045 (hide)

Owner Angiochem Inc.

Inventors Castaigne, Jean-Paul; Demeule, Michael; Gagnon, Catherine; Lawrence, Betty

Agent Pizzeys

Pub. Number AU-A-2009322045

PCT Pub. Number WO2010/063124

Priority 61/200,947 05.12.08 US

Filing date 7 December 2009

Wipo publication date 10 June 2010

International Classifications

C07K 19/00 (2006.01) Hybrid peptides

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/575 (2006.01) Peptides having more than 20 amino acids

C07K 14/81 (2006.01) Peptides having more than 20 amino acids - Protease inhibitors

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

7 July 2011 PCT application entered the National Phase

  PCT publication WO2010/063124 Priority application(s): WO2010/063124

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009322051-Security system for optical plug-in connector

2009322044-Leptin and leptin analog conjugates and uses thereof